Genotype and Intensive Pretreatment Influence Outcome of Acute Myeloid Leukemia Patients Treated With Venetoclax in Combination With Hypomethylating Agents or Low-dose Cytarabine: "Real World" Data From Germany
基因型和强化预处理影响接受维奈托克联合去甲基化药物或低剂量阿糖胞苷治疗的急性髓系白血病患者的预后：来自德国的“真实世界”数据
期刊:Hemasphere
影响因子:14.6
doi:10.1097/HS9.0000000000000759
Braitsch, Krischan; Schmalbrock, Laura K; Jung, Paul; Bumeder, Irmgard; Kiewe, Philipp; Hecker, Judith S; Verbeek, Mareike; Westermann, Jörg; Bullinger, Lars; Keller, Ulrich; Bassermann, Florian; Krönke, Jan; Götze, Katharina S; Rieger, Kathrin
